FDA-APPROVED INDICATIONS Injection Weight loss (adults) As an adjunct to diet and exercise for weight loss in adults with a BMI 30 or 27 in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia) [STEP 1 study] Adult BMI calculator Weight loss (children 12 years old) As an adjunct to a reduced-calorie diet and increased physical activity in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex
For example, people using these types of medications have reported gastrointestinal (GI) side effects such as vomiting, constipation and heartburn
And if we keep thinking its about the genes its not
Reddy's Laboratories , Zydus Group , Lupin Pharmaceuticals , NATCO Pharma , and Biocon have already signaled interest in developing semaglutide generics
Both medications are effective for treating diabetes
The risk is particularly relevant if you're using tirzepatide for weight loss while also taking NAD for purported anti-aging or metabolic benefits